Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from IDEXX Laboratories

Idexx Laboratories Stock: Is Wall Street Bullish or Bearish?

IDEXX Laboratories' stock has significantly outperformed the broader market over the past year, but analysts are cautiously bullish about its growth potential.

Barchart

Why a Company You’ve Never Heard of Is One of the Best Nasdaq-100 Stocks of the Year

Going under the radar, shares of this vet tech company have been winners this year.

Barchart

Tesla, Delta Air, IDEXX Laboratories And More On CNBC's 'Final Trades'

In a volatile market landscape marked by rapid shifts in investor sentiment, financial experts are spotlighting key stocks and sectors poised for growth. On CNBC's “Halftime Report Final Trades,” Bryn Talkington, Managing Partner of Requisite Capital Management, recommended sticking with Tesla, Inc. (NASDAQ:TSLA).

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Wayfair, CommScope Holding, Steelcase, IDEXX Laboratories And Other Big Stocks Moving Higher On Monday

U.S. stocks were higher, with the Dow Jones index gaining around 400 points on Monday.

Benzinga

IDEXX Surpasses Earnings Expectations, Justifying Premium Valuation

Pet healthcare is witnessing a surge in demand as more households prioritize their pets’ well-being, driving companies in this sector to outperform expectations. This trend is reflected in IDEXX Laboratories Inc.‘s (NASDAQ:IDXX) recent financial results, showcasing significant growth and revised earnings guidance.

Benzinga

Is IDEXX Laboratories Stock Outperforming the Dow?

IDEXX Laboratories has outpaced the Dow Jones Industrial Average this year, and analysts are reasonably upbeat about its future growth potential.

Barchart

IDEXX Laboratories Stock: Analyst Estimates & Ratings

IDEXX Laboratories has significantly outperformed the broader market in recent months, and analysts remain cautiously optimistic about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Is IDEXX Laboratories Stock Underperforming the Nasdaq?

Despite IDEXX Laboratories’ underperformance relative to the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Do Wall Street Analysts Like IDEXX Laboratories Stock?

IDEXX Laboratories has significantly outperformed the broader market in 2025 and analysts remain bullish on the stock’s prospects.

Barchart

IDEXX Laboratories' Quarterly Earnings Preview: What You Need to Know

IDEXX Laboratories plans to report its fiscal fourth-quarter earnings next month, and analysts expect its profit to rise in the single digits.

Barchart

Is IDEXX Laboratories Stock Underperforming the S&P 500?

IDEXX Laboratories has continued to underperform the S&P 500 over the past year, yet analysts remain moderately bullish on the stock’s prospects.

Barchart

A Glimpse Into The Expert Outlook On IDEXX Laboratories Through 5 Analysts

5 analysts have shared their evaluations of IDEXX Laboratories (NASDAQ:IDXX) during the recent three months, expressing a mix of bullish and bearish perspectives.

Benzinga

IDEXX Laboratories' Q3 2024 Earnings: What to Expect

IDEXX Laboratories is scheduled to release its fiscal third-quarter earnings this month, and analysts project a single-digit profit growth.

Barchart

How Is IDEXX Laboratories' Stock Performance Compared to Other Healthcare Stocks?

IDEXX Laboratories underperformed the broader healthcare sector, but Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink?

IDEXX Laboratories has underperformed the broader market over the past year, yet analysts remain moderately bullish on the stock’s prospects.

StockNews.com

3 High-Profitability Healthcare Stocks to Buy for Consistent Returns

The healthcare industry's growth is driven by expanding healthcare needs, fast-rising demand for care services, and the increasing demand for smart medical devices. Given this backdrop, investors could consider buying fundamentally strong healthcare stocks such as IDEXX Laboratories (IDXX), Veeva Systems (VEEV), and Chemed Corporation (CHE) given their solid profitability…

Barchart

IDEXX Laboratories Stock: Is IDXX Underperforming the Healthcare Sector?

IDXX Laboratories has recently underperformed the Healthcare sector, but Wall Street analysts are moderately optimistic about the stock’s prospects.

StockNews.com

T2 Biosystems (TTOO) vs. IDEXX Laboratories (IDXX): Which Medical Stock Is Poised for More October Gains?

With an aging population worldwide, the rising prevalence of chronic diseases, and numerous technological advancements, the medical device sector stands primed for considerable growth and expansion. The industry tailwinds should benefit medical device stocks T2 Biosystems (TTOO) and IDEXX Laboratories (IDXX). However, which stock is poised for better gains this…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2022

Upgrades

Benzinga

Here's How Much $100 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth Today

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years by 3.0% on an annualized basis producing an average annual return of 9.28%. Currently, IDEXX Laboratories has a market capitalization of $30.26 billion.

Benzinga

4 Analysts Have This to Say About IDEXX Laboratories

Over the past 3 months, 4 analysts have published their opinion on IDEXX Laboratories (NASDAQ:IDXX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

$1000 Invested In This Stock 20 Years Ago Would Be Worth $12,000 Today

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 20 years by 6.71% on an annualized basis producing an average annual return of 13.47%. Currently, IDEXX Laboratories has a market capitalization of $28.24 billion.

Benzinga

Here's How Much $100 Invested In IDEXX Laboratories 5 Years Ago Would Be Worth Today

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 5 years by 6.05% on an annualized basis producing an average annual return of 16.93%. Currently, IDEXX Laboratories has a market capitalization of $31.37 billion.

StockNews.com

Zoetis vs. IDEXX Laboratories: Which Animal-Health Services Stock is a Better Buy?

Rising pet ownership and an increasing focus on healthy livestock have boosted the demand for animal healthcare solutions. Therefore, animal healthcare service providers Zoetis (ZTS) and IDEXX Laboratories (IDXX) should benefit. But the stocks of which of these two companies is a better buy now? Read on to learn our…

1 2

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Palantir Technologies

Read news from The Economist, FT, and more,
with one subscription

Topics

Ocean

6,090 stories

Dow Jones Industrial Average

226 stories

Places

United States

314,198 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.